Drug Approval Package

Fosamax (alendronate sodium) Tablets
Company:  Merck Research Laboratories
Application No.:  020560, S18
Approval Date: 11/24/1999

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)   

• Medical Review(s) (PDF)  
  Part 1 (PDF)  
  Part 2 (PDF)  

• Statistical Review(s) (PDF)  

• Administrative Document(s) & Correspondence (PDF)

Date created: April 24, 2003

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.